⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

May 11, 2021Infectious Diseases and TherapyOpen Access

Meta-Analysis of Efficacy and Safety of Coformulated Bictegravir, Emtricitabine, and Tenofovir Alafenamide Among People Living with HIV

I‐Wen Chen Hsin‐Yun Sun Chien‐Ching Hung

View Full Paper

Ask AI

Bookmark

Share

Ask about this paper

Answers are grounded in this paper and cite their sources.

Ask your own question…

Abstract

This meta-analysis of published randomized clinical trials of antiretroviral-naïve and stably antiretroviral-treated PLWH suggests that BIC/FTC/TAF is as safe and efficacious as are its comparators at week 48. The interstudy differences in selected populations and control regimens may lead to the high heterogeneity of the meta-analysis.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Chen et al. (2021) studied this question.

synapsesocial.com/papers/69d856e452654bb436d1923b https://doi.org/10.1007/s40121-021-00449-z

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 10 related papers. Consider them for comparative context:

1Current and future priorities for the development of optimal HIV drugsReview · 2018 · 53 citations
2Measuring inconsistency in meta-analyses2003 · 63,796 citations
3The Cochrane Collaboration's tool for assessing risk of bias in randomised trialsRisk Assessment · 2011 · 34,402 citations
4Estimating the sample mean and standard deviation from commonly reported quantiles in meta-analysisMeta-Analysis · 2020 · 869 citations
5Switching to Fixed-Dose Bictegravir, Emtricitabine, and Tenofovir Alafenamide (B/F/TAF) in Virologically Suppressed HIV-1 Infected Women: A Randomized, Open-Label, Multicenter, Active-Controlled, Phase 3, Noninferiority TrialRCT · 2019 · 56 citations
6Switching to Bictegravir, Emtricitabine, and Tenofovir Alafenamide in Virologically Suppressed Adults With Human Immunodeficiency VirusRCT · 2020 · 120 citations
7Patient-Reported Symptoms Over 48 Weeks Among Participants in Randomized, Double-Blind, Phase III Non-inferiority Trials of Adults with HIV on Co-formulated Bictegravir, Emtricitabine, and Tenofovir Alafenamide versus Co-formulated Abacavir, Dolutegravir, and LamivudineCohort Study · 2018 · 60 citations
8Antiviral Activity of Bictegravir (GS-9883), a Novel Potent HIV-1 Integrase Strand Transfer Inhibitor with an Improved Resistance ProfileOriginal Research · 2016 · 303 citations
9Comparison of Respiratory Syncytial Virus Versus Influenza-Associated Acute Respiratory Illness Hospitalizations Among Adults in North AmericaInfectious Diseases and Therapy · 2026
10Rotavirus Vaccine Effectiveness Against Hospitalization for Rotavirus Gastroenteritis in Children Under 5 years: A Test-Negative Study in Southern Italy, 2018–2025Infectious Diseases and Therapy · 2026

More from Infectious Diseases and Therapy

More from University of Toronto

More from National Taiwan University

More from National Taiwan University Hospital